SPRC | SciSparc Ltd. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.2014 - 0.2281
52 Week Range	0.2010 - 6.78
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	602,135
Average Volume	754,223
Shares Outstanding	10,357,108
Market Cap	2,209,171
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-08-30

Valuation
Profitability
Growth
Health
P/E Ratio	-0.04
Forward P/E Ratio	N/A
EPS	-5.28
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	3
Country	Israel
Website	SPRC

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

SPRC's peers: BNOX, ONCS, VRAX, HILS, ZVSA, UNCY, QNRX, CDIO, PXMD, YS, CVKD, VIRI, HOTH, NLTX, CTMX, ASMB, TIL, NUVB, BWV, REVB, KPRX, TLSA, STSSW

*Chart delayed

Analyzing fundamentals for SPRC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see SPRC Fundamentals page.

Watching at SPRC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SPRC Technicals page.